Renaissance Technologies »

Aardvark Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-03-31 $267k 71k 3.77

More positions owned by Renaissance Technologies

United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Apple (AAPL)
Kinross Gold Corp (KGC)
Micron Technology (MU)
Verisign (VRSN)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
Sandisk Corp (SNDK)
NVIDIA Corporation (NVDA)
Chevron Corporation (CVX)
Roblox Corp Cl A (RBLX)
Carvana Cl A (CVNA)
Wayfair Cl A (W)
Robinhood Mkts Com Cl A (HOOD)

View all positions for Renaissance Technologies

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Capital Management
Polygon Management
Geode Capital Management
Adage Capital Partners GP
State Street Corporation
Two Sigma Investments
UBS Group
AQR Capital Management
Millennium Management
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Aardvark Therapeutics